- “Metformin Hydrochloride Tablets” already exists in your wishlist
In Stock
Erlotinib Tablets
Erlotinib Tablets 100mg | Anti-Cancer
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic medicine information • Updated 16 October 2026
Important: This is an educational guide, not a prescription or a substitute for advice from your cancer specialist.
Product Introduction
Erlocip 100 Tablet contains erlotinib 100 mg and is marketed by Cipla Ltd. Erlotinib is a targeted anticancer medicine used for certain cases of non-small cell lung cancer and pancreatic cancer.
This is a prescription-only medicine. The appropriate dose and duration depend on the cancer type, test results, other treatments, response and tolerability. Do not decide your dose from the tablet strength alone.
1. Uses
Used in selected cases of non-small cell lung cancer (NSCLC) and pancreatic cancer, according to the approved product information and specialist assessment.
For lung cancer, suitability may depend on tumour characteristics and prior treatment. A cancer specialist should determine whether erlotinib is appropriate.
2. Benefits
Erlotinib blocks the epidermal growth factor receptor (EGFR) tyrosine kinase, which can help interrupt signals that tell certain cancer cells to grow.
In patients whose cancer is appropriate for this treatment, it may slow cancer growth or help control disease. The benefit depends on diagnosis, tumour features and individual response.
3. Side Effects
Common side effects include rash or acne-like skin changes, diarrhoea, nausea, vomiting, fatigue, reduced appetite, weight loss, abdominal pain, dry or itchy skin, mouth sores, cough and infection.
Seek urgent medical care for new or worsening breathing difficulty, severe or persistent diarrhoea, blood in stools, severe abdominal pain, yellowing of the skin or eyes, unusual bleeding, or painful/red eyes or changes in vision.
Rare but serious problems can include interstitial lung disease, severe skin reactions, gastrointestinal perforation and liver injury. Contact the treating team promptly about new or worsening symptoms.
4. Safety Advice
Take only as prescribed by your oncologist. Do not change the dose or stop treatment without medical advice.
Your doctor may arrange regular liver-function tests and assess side effects, hydration and nutritional status.
Tell your doctor if you have liver or kidney disease, eye problems, stomach or intestinal disorders, or if you take anticoagulants or statins.
Pregnancy: erlotinib may harm an unborn baby. Tell your doctor if pregnant, planning pregnancy or if pregnancy occurs. Use effective contraception during treatment and for at least 1 month after the last dose, as advised by your specialist.
Breastfeeding is not recommended during treatment; ask your doctor when it may be safe to resume.
Skin may become more sensitive to sunlight. Use sun protection and protective clothing. Ask your doctor about alcohol.
Smoking can reduce erlotinib exposure and effectiveness. Tell your doctor if you smoke or stop smoking; do not adjust the dose yourself.
Store below 30°C as stated on the product information and keep out of reach of children.
5. How It Works
Erlotinib is an EGFR tyrosine kinase inhibitor. It blocks signals involved in the growth and division of certain cancer cells, which may slow their progression.
6. How to Use
Follow the exact dose and schedule prescribed by your specialist. The 100 mg strength does not mean every patient should take one tablet daily.
Take on an empty stomach, at least 1 hour before or 2 hours after a meal. Swallow the tablet whole with water; do not chew, crush or break it unless a clinician or pharmacist gives specific instructions.
Medicines that reduce stomach acid can affect erlotinib absorption. Check with your doctor or pharmacist before using antacids, H2 blockers or proton-pump inhibitors. If an antacid is approved, separate it from erlotinib by at least 2 hours as directed by your care team.
If you miss a dose, vomit after taking it, or think you took too much, follow the package leaflet or contact your care team. Do not double a dose unless instructed.
Continue only for as long as your specialist prescribes. Do not stop because you feel better without medical advice.
7. Quick Tips
Take the tablet consistently at the prescribed time and maintain the required empty-stomach interval.
Drink adequate fluids and contact your doctor if diarrhoea is persistent, severe or accompanied by blood.
Use sunscreen and protective clothing; report a severe rash or eye pain/vision changes promptly.
Keep a current list of all prescription medicines, over-the-counter products, vitamins and herbal supplements and share it with your oncology team.
Keep all follow-up appointments and recommended liver-function tests.
8. Drug Interactions
Erlotinib can interact with medicines that affect CYP3A4 or stomach acidity. Examples include certain antifungals and antibiotics, rifampicin, some seizure medicines, St John’s wort, acid-reducing medicines, and some anticoagulants such as warfarin.
Smoking can reduce erlotinib levels. Do not start or stop any medicine, supplement or herbal product, or change smoking habits without telling your prescriber. The examples above are not a complete interaction list.
Medical Disclaimer
This document is for general educational purposes only and is not a substitute for medical advice, diagnosis or treatment. Erlotinib is a specialist-prescribed anticancer medicine. Do not use this guide to select a dose or make treatment decisions. Always follow the current package leaflet and the instructions of your oncologist or pharmacist. In an emergency, seek urgent medical care.
| Product Name | Erlotinib Tablets |
| Category | All Medicines, Anti Cancer |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 100mg |
|---|
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
